Neuland Reports Strong FY26 Revenue And Margin Gains
ECONOMY & POLICY

Neuland Reports Strong FY26 Revenue And Margin Gains

Neuland Laboratories Limited reported annual results for the year ended 31 March 2026, with total income of Rs. 20,531 mn and EBITDA of Rs. 6,034 mn. The company said Q4FY26 revenue stood at Rs. 7,887 mn while Q4 EBITDA was Rs. 3,194 mn, reflecting strong sequential performance. Management noted robust operating leverage and improved margins during the fourth quarter.

EBITDA margin for Q4FY26 was 40.5 per cent, up from 17.3 per cent a year earlier, representing an increase of 2316 basis points. Profit before tax for the quarter was Rs. 2,870 mn and profit after tax was Rs. 2,125 mn. Year-on-year Q4 income rose 134.9 per cent while EBITDA increased 448.6 per cent and profit after tax grew 666.3 per cent.

The chief executive officer and managing director said the company had ended FY26 on a strong note and that business visibility was good in the short to medium term, anchored by commercial and near-commercial molecules. He said the company would focus on execution discipline, customer satisfaction and protection of business fundamentals while laying the groundwork for growth beyond the immediate horizon. Investments in peptide manufacturing and a new research and development centre were reported to be proceeding according to plan and business development efforts were being aligned to attract projects that support high quality, sustainable growth.

The company scheduled a one-hour earnings call at 17:30 IST on Tuesday, 12 May 2026, and said the transcript would be uploaded to the corporate website in due course. Neuland was described as a cGMP manufacturer with over four decades of experience, more than 300 developed processes, about 100 APIs and around 1000 regulatory filings across major jurisdictions, supported by multiple global certifications.

Neuland Laboratories Limited reported annual results for the year ended 31 March 2026, with total income of Rs. 20,531 mn and EBITDA of Rs. 6,034 mn. The company said Q4FY26 revenue stood at Rs. 7,887 mn while Q4 EBITDA was Rs. 3,194 mn, reflecting strong sequential performance. Management noted robust operating leverage and improved margins during the fourth quarter. EBITDA margin for Q4FY26 was 40.5 per cent, up from 17.3 per cent a year earlier, representing an increase of 2316 basis points. Profit before tax for the quarter was Rs. 2,870 mn and profit after tax was Rs. 2,125 mn. Year-on-year Q4 income rose 134.9 per cent while EBITDA increased 448.6 per cent and profit after tax grew 666.3 per cent. The chief executive officer and managing director said the company had ended FY26 on a strong note and that business visibility was good in the short to medium term, anchored by commercial and near-commercial molecules. He said the company would focus on execution discipline, customer satisfaction and protection of business fundamentals while laying the groundwork for growth beyond the immediate horizon. Investments in peptide manufacturing and a new research and development centre were reported to be proceeding according to plan and business development efforts were being aligned to attract projects that support high quality, sustainable growth. The company scheduled a one-hour earnings call at 17:30 IST on Tuesday, 12 May 2026, and said the transcript would be uploaded to the corporate website in due course. Neuland was described as a cGMP manufacturer with over four decades of experience, more than 300 developed processes, about 100 APIs and around 1000 regulatory filings across major jurisdictions, supported by multiple global certifications.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code